In children with cystic fibrosis (CF), certain genetic variants were found to be associated with the rate of absorption…
Andrea Lobo, PhD
Andrea Lobo holds a Biology degree, and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
The Cystic Fibrosis Foundation (CFF) has joined the CEO Action for Diversity and Inclusion, adding its name to…
The U.S. Food and Drug Administration (FDA) approved the expanded use of …
A poorer adherence to pulmonary therapies does not seem to greatly influence disease severity in patients with cystic fibrosis…
A defect in an anti-inflammatory pathway called IL-37-SIGIRR contributes to the hyperinflammation seen in lung epithelial cells in patients with…
The clinical outcome of lung infection with Mycobacterium abscessus (M. abscessus)Â in cystic fibrosis (CF) patients is associated with genetic…